GVK Bio is now known as Aragen. How is the name change going to have an impact on the brand?
The re-branding exercise has given us an opportunity to re-discover ourselves as an organisation and build upon it. The company has grown from strength to strength over the last 20 years. While our values remain the same, it is now aligned to the new brand promise and purpose, something that is imbibed by each and every employee of the organisation. This rebranding initiative enabled us to streamline and bring in a clear focus to our vision for success. Aragen is a name known for its scientific expertise and customer-centric culture in the West. We are now investing in branding around the name – our initial feedback from both current and prospective customers has been very positive. They love our new identity and our renewed purpose and promise. The number of positive responses in the social media from all our internal and external stakeholders is a testimony to the liking of our new identity. This new brand identity is well poised to launch Aragen into this exciting future.
What are the plans in store following the recent investment by Goldman Sachs?
Continue reading your story on the app
Continue reading your story in the magazine
How Tech Innovations Impact Cardiac Care
Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.
Mynvax Offers ‘Warm Vaccine' For COVID-19
Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.
“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”
Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;
Premas Biotech to commercialise VLP vaccine tech against Delta variant
Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.
SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future
The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!
Merck launches Pergoveris Pen for fertility treatment in India
Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.
GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B
While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.
Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray
Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation
CEPI prioritises Rift Valley fever vax
Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.
3D printing moulds healthcare innovations
Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.
BELLANDUR LAKE FROTH - Debasish Ghosh
Bangalore, India, was once known for its interconnected lake systems, which provided a reliable water source. As the city grew, these lakes have encroached, and the water became polluted day by day. The largest, Bellandur Lake, now carry huge volumes of snowy froth, which block the adjacent canals.
CROWNING GLORY
Bengaluru-based philanthropist Kulsum Shadab Wahab is empowering acid attack survivors with her award-winning headgear brand, Ara Lumiere.
SHUTTING DOWN STUNTS
Bengaluru is going all out to thwart bikers from racing and performing wheelies on public roads
Karnataka CM takes U-turn on ‘moral policing'
CHIEF Minister Basavaraj Bommai, who had said his government will deal with ‘moral policing’ with an iron hand following an incident in Bengaluru a month ago, did a volte-face in Mangaluru on Wednesday saying, “Action and reaction are bound to happen when there is no morality in society.”
“Always Let People Do Their Job”
“It’s hard to let go when you are still young. We managed to do really well in hiring the first core team, and that is the most critical part of our story.”
Rasode me kaun tha? Robot chef
The pandemic has led to an uptick in sales of kitchen gadgets. Now, a bunch of startups are trying to persuade restaurants and home cooks to embrace automation
RPF women's team seizes crystal meth worth ₹3.2 cr
IN one of the biggest drug busts made in the country inside railway premises, an all-women team of the Railway Protection Force (RPF) on Friday seized 640 grams of the recreational drug, crystal Methamphetamine, worth nearly ₹3.2 crore from a train passenger.
Let your kids get bored to nurture their creativity
It’s not uncommon these days to‘structure’ your children’s free time.
44% millennials skipped breakfast amid pandemic
A recent study has shown that 44 per cent of urban millennials skipped breakfast in times of COVID and delayed meals due to increased household chores and late start to the day.
इंडिगो को महंगे तेल से लगेगा झटका
इंटरग्लोब एविएशन (इंडिगो) का शेयर बीएसई पर सोमवार के कारोबार में 2.76 प्रतिशत गिरकर 2,080 रुपये पर आ गया था, क्योंकि तेल कीमतों में तेजी और विमानन उद्योग में अधिक आपूर्ति की स्थिति से बाजार की चिंता बढ़ी है।